Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

類似資料

• Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
  著者:: Dai, Hanren, 等
  出版事項: (2020)
• Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphoma
  著者:: Tong, Chuan, 等
  出版事項: (2020)
• Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
  著者:: Hejin Jia, 等
  出版事項: (2019-06-01)
• Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation
  著者:: Jia, Hejin, 等
  出版事項: (2019)
• Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment
  著者:: Guo, Yelei, 等
  出版事項: (2020)